Department of Dermatology

Patient-oriented Comparison of Systemic Therapies for Patients with advanced Melanoma - A multicenter Cross-sectional Study (2021) Thiem A, Mashhadiakbar P, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, Heppt M, et al. Conference contribution Clinical Prognostic Factors in metastatic Choroidal Melanoma (2021) Koch E, Petzold A, Wessely A, Dippel E, Erdmann M, Heinzerling L, Hohberger B, et al. Conference contribution Elective Discontinuation of Checkpoint Inhibitor Therapy in Patients with advanced Melanoma (2021) Persa OD, Schatton K, Ruebben A, Berking C, Erdmann M, Schlaak M, Mauch C, Steeb T Conference contribution Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging (2021) Lazic D, Kromp F, Rifatbegovic F, Repiscak P, Kirr M, Mivalt F, Halbritter F, et al. Journal article Long-term Effectiveness of Interventions for actinic Keratoses: Results of a systematic Review and Network Meta-Analysis (2021) Steeb T, Wessely A, Petzold A, Brinker T, Schmitz L, Lei-Ter-Stoppke U, Garbe C, et al. Conference contribution Development of a digital Teaching Project on the Topic of "Immunooncology" (2021) Kaufmann M, Berking C, French LE, Meyerolbersleben M, Reinholz M, Steeb T, Heppt M Conference contribution Serositis in Association with System Therapy with Checkpoint Inhibitors - More frequent than thought? - An Evaluation of the SERIO Adverse Event Registry (2021) Zierold S, Kramer R, Erdmann M, Akcetin SL, Maier AM, Koenig A, Theurich S, et al. Conference contribution YouTube (R)-Videos about Skin Cancer as an Information Source for Patients: Assessment of quality, Comprehensibility and Reliability (2021) Reinhardt L, Steeb T, Harlass M, Brutting J, Berking C, Meier F Conference contribution The Nectin-1 Expression correlates with the Susceptibility of malignant Melanoma to oncolytic Herpes Simplex Viruses in vitro and in vivo (2021) Schwertner B, Linder G, Stauner CT, Klapproth E, Magnus C, Rohrhofer A, Gross S, et al. Conference contribution A novel antiproliferative, pro-apoptotic Approach for the Treatment of actinic Keratoses: Tirbanibulin (KX2-391) (2021) Heppt M, Ocker WG, Melzer A Conference contribution